ABGABEVORRICHTUNG

Patent europeic · EP4333770 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4333770
Numer da la dumonda
EP22728269
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-05-2022
Publitgà
13-03-2024
Concedì
01-07-2026
La protecziun finescha il pli tard
03-05-2042
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61F 2/24 (2006.01)
A61M 25/01 (2006.01)
A61F 2/95 (2013.01)
A61M 25/06 (2006.01)
A61M 25/00 (2006.01)
Prioritad
US 202163184403 P 05.05.2021
US 202163184427 P 05.05.2021
Dumonda PCT
PCT/IB2022/054099 04.05.2022
Publicaziun PCT
WO2022/234468 10.11.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.07.2026

Partidas

Possessur

Innovalve Bio Medical Ltd.

c/o Cardiac Surgery Department 2nd floor Sheba Medical Center Tel Hashomer, 5265601 Ramat-Gan, IL

Inventur

SHIMEL, Guy

6941514 Tel Aviv-Jaffa, IL

AGIAN, Nadav

4030067 Kfar Yona, IL

BAROR, Eyal

7314000 Bet Nehemia, IL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.